Healthcare
VCYT
Veracyte, Inc.
$43.34-4.22%
Add to Watchlist
Loading chart...
About Veracyte, Inc.
Veracyte develops diagnostic tests that help doctors identify cancer in patients. The company's main tests examine tissue or fluid samples to detect thyroid, prostate, bladder, breast, and lung cancers. These tests use genetic sequencing and analysis to determine whether a patient's tumor is likely to be dangerous or slow-growing. The company also provides laboratory equipment and services that analyze genetic material.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore